•   English  
  • /
  •   中文
HomeHome
About usNav
R&D and servicesNav
Product centerNav
NewsNav
CareersNav
Contact UsNav
Company overviewAwards & RecognitionsR&D IntroductionGeneric drug R&D platformGeneric drug consistency evaluationInnovative drug R&D platformBiopharmaceutical R&D platformTherapeutic antibody development platformClinical research platformSafety evaluation centerCommon ReagentsSustained and controlled release preparationsLiquid preparationExternal preparationCategory 4 generic drugsCategory 3 generic drugsInnovative drugBiopharmaceuticstherapeutic antibodyPress ReleasesIndustry newsCareer developmentEnterprise UniversityCareer OpportunitiesCampus recruitment
Product center
Common Reagents
Sustained and controlled release preparations
Liquid preparation
External preparation
Category 4 generic drugs
Category 3 generic drugs
Innovative drug
Biopharmaceutics
therapeutic antibody
Common reagents

Common reagents

副标题

LCZ696 Tablets
Zontivity,Vorapaxar Tablets
Rexulti,brexpiprazole Tablets
Januvia,Sitagliptin phosphate Tablets
ROZEREM,Ramelteon Tablets
ULORIC,Febuxostat Tablet
Suglat,Ipragliflozin L-Proline Tablets
URIADEC Tab,Topiroxostat Tablets
Isosorbide Mononitrate Sustained Release Tablets
Prev 1 Next
Mobile version |This website usesFAISCOBuild | Login | 京ICP备19022547号-1 | 本站支持  --